Grants and Contributions:

Back to search

Title:

515281

Agreement Number:

515281

Agreement Value:

$38,009,500.00

Agreement Date:

Apr 1, 2024 - Mar 31, 2029

Description:

BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new cancer immunotherapies.

Organization:

Innovation, Science and Economic Development Canada

Expected Results:

Immediate:
- Interdisciplinary and equity-focused research, training and learning is conducted;
- Increased collaboration among academia, research institutes, non-profit, private and public sector, and diverse international and community organizations;
Intermediate:
- Scientific knowledge is produced and disseminated to diverse end users;
- Scientific literacy and scientific skills are developed among diverse target populations;
Ultimate:
- Scientific research and innovation produces economic, societal and health benefits; and
Skilled, diverse people fulfill industry and societal needs.

Location:

Ottawa, Ontario, CA K1H8L6

Reference Number:

033-2024-2025-Q1-515281

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

819855180

Recipient Type:

Other

Additional Information:

2024/25 to 2028/29, - Recipient Type Other

Recipient's Operating Name:

BioCanRx

Recipient's Legal Name:

BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancer

Federal Riding Name:

Ottawa South

Federal Riding Number:

35077

Program:

SSF - Science & Research

Program Purpose:

The Strategic Science Fund (SSF) aims to mobilize the expertise and resources of independent science and research not-for-profit organizations to enhance Canada's science, technology and innovation (ST&I) excellence. SSF investments will achieve results for Canadians by addressing critical needs, such as supporting Canada's knowledge economy, in areas or in ways that advance federal objectives. The SSF program is jointly administered by Innovation, Science and Economic Development Canada (ISED) and Health Canada, via a Program Management Committee and Steering Committee.

NAICS Code:

541710